Idexx Laboratories (IDXX) Receivables - Other (2018 - 2026)

Idexx Laboratories' Receivables - Other history runs 9 years deep, the most recent figure standing at $318.7 million for Q1 2026.

• In Q1 2026, Receivables - Other rose 26.07% year-over-year to $318.7 million; the TTM figure through Mar 2026 stood at $318.7 million (up 26.07% YoY), while the FY2025 annual figure was $312.7 million, up 26.96% from the prior year.
• Receivables - Other was $318.7 million for Q1 2026 at Idexx Laboratories, up from $312.7 million in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $318.7 million in Q1 2026 to a low of $172.6 million in Q1 2022.
• Historically, Receivables - Other has averaged $233.9 million across 5 years, with a median of $230.0 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Receivables - Other surged 40.78% in 2022, then rose 9.91% in 2025.
• A 5-year view of Receivables - Other shows it stood at $190.8 million in 2022, then climbed by 16.93% to $223.1 million in 2023, then climbed by 10.4% to $246.3 million in 2024, then rose by 26.96% to $312.7 million in 2025, then increased by 1.92% to $318.7 million in 2026.
• The last three Receivables - Other figures came in at $318.7 million (Q1 2026), $312.7 million (Q4 2025), and $288.7 million (Q3 2025), per Business Quant data.